Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             178 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 63A A cost comparison of the use of exclusive chart abstraction to the use of an on-line obstetrical database for the obstetrical triage study Leeke, Terry
 1994
 15 3S1 p. 74-75
2 p.
 artikel
2 14A A design for assessing clinical benefit for patients with advanced pancreatic cancer Andersen, John S.
 1994
 15 3S1 p. 41-
1 p.
 artikel
3 57A Adverse experience reporting Neaton, James
 1994
 15 3S1 p. 71-
1 p.
 artikel
4 04A An evaluation of new designs for phase I clinical trials Odom-Maryon, Tamara
 1994
 15 3S1 p. 34-
1 p.
 artikel
5 51A Applying lessons learned at DOD to pharmaceutical research systems and security Harney, Hugh
 1994
 15 3S1 p. 67-68
2 p.
 artikel
6 19A Assessing the quality of reports of randomized controlled trials: Current issues and future directions Moher, David
 1994
 15 3S1 p. 44-45
2 p.
 artikel
7 18A Assessment of participant satisfaction in a clinical trial by an exit questionnaire Nasco, Elaine M.
 1994
 15 3S1 p. 43-44
2 p.
 artikel
8 33A Assessment of the variation of treatment effect over time: An example in hypertension treatment Boutitie, Florent
 1994
 15 3S1 p. 55-
1 p.
 artikel
9 09A A survey of internet and commercial information utility uses in clinical trials Singer, Stephen W.
 1994
 15 3S1 p. 37-38
2 p.
 artikel
10 65A Automated forms processing: Trials, tribulations and triumphs Wong, Kenneth
 1994
 15 3S1 p. 76-
1 p.
 artikel
11 56A Automated matching of adverse medical event descriptions to costart Day, Philip L.
 1994
 15 3S1 p. 70-71
2 p.
 artikel
12 17A Bayesian designs for clinical trials with multiple endpoints Thall, Peter F.
 1994
 15 3S1 p. 43-
1 p.
 artikel
13 44A Comparing results from the largest studies with meta-analyses of smaller studies Chalmers, Thomas C.
 1994
 15 3S1 p. 63-
1 p.
 artikel
14 66A Computer assisted quality control of the publication process for a clinical cooperative group: The RTOG model Turner, Martha W.
 1994
 15 3S1 p. 76-
1 p.
 artikel
15 37A Considering changing the primary outcome of a clinical trial after examining the data: The modification of diet in renal disease (MDRD) study Greene, T.
 1994
 15 3S1 p. 57-
1 p.
 artikel
16 16A Construction of composite outcome measures for clinical trials using variables standardized with respect to referent samples McDermott, Michael P.
 1994
 15 3S1 p. 42-
1 p.
 artikel
17 34A Data analysis when using compliance data from clinical trials Sereika, Susan
 1994
 15 3S1 p. 55-56
2 p.
 artikel
18 31A Data management for multicenter clinical trials: Slowly distributed systems Mitchell, Herman E.
 1994
 15 3S1 p. 53-54
2 p.
 artikel
19 30A Data management systems for concurrent protocols: The experience of the NICHD networks' data center Zachary, Julia
 1994
 15 3S1 p. 53-
1 p.
 artikel
20 48A Data management training through worksheets and games Houston, Collette M.
 1994
 15 3S1 p. 65-66
2 p.
 artikel
21 62A Decision rules for predicting future lipid values in a cholesterol reduction clinical trial Moye, Lemuel A.
 1994
 15 3S1 p. 74-
1 p.
 artikel
22 05A Design considerations for phase II neuroclinical trials Alves, Wayne M.
 1994
 15 3S1 p. 34-35
2 p.
 artikel
23 49A Development of a centralized data management and computing resource at a large academic clinical research center Begg, Colin B.
 1994
 15 3S1 p. 66-
1 p.
 artikel
24 22A Do physicians who participate in randomized aids trials differ from those who do not? results from a national survey of Canadian physicians Taylor, Kathryn M.
 1994
 15 3S1 p. 47-
1 p.
 artikel
25 54A Drug retrievals in multi-center clinical trials Peterson, Jenine C.
 1994
 15 3S1 p. 69-70
2 p.
 artikel
26 01A Dynamic balancing of multi-center trials Mohanty, Surya
 1994
 15 3S1 p. 32-
1 p.
 artikel
27 23A Efficacy and safety of anticoagulant and antiplatelet therapy versus anticoagulant therapy after heart-valve replacement: A meta-analysis Cappelleri, Joseph C.
 1994
 15 3S1 p. 47-48
2 p.
 artikel
28 52A Efficient data modeling with a device independent data dictionary Brandmaier, R.
 1994
 15 3S1 p. 68-
1 p.
 artikel
29 41A Enhancing follow-up rate and data quality in a multicenter clinical trial: The presance study Rolland, Carole
 1994
 15 3S1 p. 60-61
2 p.
 artikel
30 36A Evaluating the impact of treatment crossovers on statistical analysis of clinical trials Melia, Michele
 1994
 15 3S1 p. 56-57
2 p.
 artikel
31 15A Evaluation of surrogate end point measures with applications to cardiovascular imaging trials Mack, Wendy J.
 1994
 15 3S1 p. 41-42
2 p.
 artikel
32 50A Evolution of Merck's clinical data management system O'Grady, Laura
 1994
 15 3S1 p. 67-
1 p.
 artikel
33 58A Experience with a factorial design in a pivotal oncology clinical trial Myles, James D.
 1994
 15 3S1 p. 72-
1 p.
 artikel
34 45A Failure to conceal treatment allocation schedules in trials influenced estimates of treatment effects Schulz, Kenneth F.
 1994
 15 3S1 p. 63-64
2 p.
 artikel
35 46A Gender bias in clinical trials? Kaplan-Gilpin, Adele M.
 1994
 15 3S1 p. 64-
1 p.
 artikel
36 13A GISSI-3: Analysis of left ventricular function by echocardiography in 14,209 patients Torta, D.
 1994
 15 3S1 p. 40-
1 p.
 artikel
37 60A Global outcome tests for rheumatoid arthritis trials Tilley, Barbara C.
 1994
 15 3S1 p. 73-
1 p.
 artikel
38 21A How clinical trial results are desseminated: use and influence of different sources of information in a survey of US physicians Rosenberg, Yves
 1994
 15 3S1 p. 46-
1 p.
 artikel
39 40A Identification of successful compliance strategies for the lipid study Hague, W.
 1994
 15 3S1 p. 60-
1 p.
 artikel
40 39A Identifying successful monitoring strategies in the GISSI-3 trial Bonfanti, E.
 1994
 15 3S1 p. 59-
1 p.
 artikel
41 53A Influence of a patient-completed symptom checklist on the subsequent reporting of adverse events in a clinical trial interview Wagner, Anita K.
 1994
 15 3S1 p. 69-
1 p.
 artikel
42 06A Influence of confounding factors on designs for dose effect studies Girard, Pascal
 1994
 15 3S1 p. 35-
1 p.
 artikel
43 20A Issues around the release of a dataset from a completed clinical trial Hewson, Sheila
 1994
 15 3S1 p. 45-
1 p.
 artikel
44 42A Limitations of the riboflavin adherence test Haakenson, Clair
 1994
 15 3S1 p. 61-62
2 p.
 artikel
45 02A Log-rank statistic for testing interaction effect in a 2 × 2 factorial design and its use in sample size determination Fawcett, Shu-chuan W.
 1994
 15 3S1 p. 32-33
2 p.
 artikel
46 38A Motivation of study coordinators in the herpetic eye disease study Banuvar, Suzanne
 1994
 15 3S1 p. 58-
1 p.
 artikel
47 25A Multiple publication of clinical trials reports: A caveat for meta-analysis Leizorovicz, Alain
 1994
 15 3S1 p. 49-
1 p.
 artikel
48 43A Patients over 70 years in a clinical trial: The experience of GISSI-3 Gardinale, E.
 1994
 15 3S1 p. 62-
1 p.
 artikel
49 24A Practical guidelines for collaboration in meta-analysis: A view from the coordinating center Collins, Dorothea
 1994
 15 3S1 p. 48-49
2 p.
 artikel
50 03A Recruitment sampling strategy and power analyses in the MMHD study Greene, Tom
 1994
 15 3S1 p. 33-
1 p.
 artikel
51 55A Remote drug treatment information system Jones, Mark S.
 1994
 15 3S1 p. 70-
1 p.
 artikel
52 35A Robust bayesian analysis of clinical trials Greenhouse, Joel B.
 1994
 15 3S1 p. 56-
1 p.
 artikel
53 61A Sample size estimation for a secondary cataract prevention trial Munsell, Mark F.
 1994
 15 3S1 p. 73-74
2 p.
 artikel
54 07A Study monitoring and data entry through use of remote fax communication (datafax) in a large multi-centre clinical trial Walker, Valery
 1994
 15 3S1 p. 36-
1 p.
 artikel
55 08A Telematic management of center monitoring in a phase IV study Rolland, Carole
 1994
 15 3S1 p. 36-37
2 p.
 artikel
56 32A The challenges of international collaboration in multicentre trials Weston, Julie
 1994
 15 3S1 p. 54-
1 p.
 artikel
57 47A The clinical research enterprise of the united States as seen through the published literature in relation to gender Levine, Charlene
 1994
 15 3S1 p. 65-
1 p.
 artikel
58 59A The influence of use functions and test statistics on power for the sequential monitoring of a clinical trial Brooks, Maria Mori
 1994
 15 3S1 p. 72-73
2 p.
 artikel
59 29A The society's electronic mailing list: A survey of clinical trials users and usage Bailey, Lance R.
 1994
 15 3S1 p. 52-
1 p.
 artikel
60 64A Towards a system for continuous patient outcome assessment: Clinical trials to clinical practice Kiri, Antariksha
 1994
 15 3S1 p. 75-
1 p.
 artikel
61 67A Trial summary report software and data base: Specifications and preliminary results Strang, Nigel
 1994
 15 3S1 p. 77-
1 p.
 artikel
62 27A Use of cumulative meta analysis in the design, conduct, and analysis of a clinical trial Henderson, William G.
 1994
 15 3S1 p. 50-51
2 p.
 artikel
63 28A Using a relational database management system for management of revision-dependent data LoPresti, Frances
 1994
 15 3S1 p. 51-
1 p.
 artikel
64 Author index 1994
 15 3S1 p. 139-153
15 p.
 artikel
65 26A Why must we perform meta-analyses on individual patient data? The indana project: An example of hypertension Gueyffier, Francois
 1994
 15 3S1 p. 50-
1 p.
 artikel
66 Fifteenth annual meeting of the society for clinical trials 1994
 15 3S1 p. 3-30
28 p.
 artikel
67 58P A comparison of compliance measures and the effect of compliance rates on efficacy results Ng, Jennifer
 1994
 15 3S1 p. 110-
1 p.
 artikel
68 85P A comparison of interim analyses using the triangle test and the restricted procedures/alpha spending function-experience with two clinical trials Thorn, Michael
 1994
 15 3S1 p. 124-125
2 p.
 artikel
69 04P A comparison of methods to analyze longitudinal B-mode ultrasound data Craven, Timothy
 1994
 15 3S1 p. 79-80
2 p.
 artikel
70 69P A computerized system for frequent dosage adjustments in a clinical trial Thomas, Kathy B.
 1994
 15 3S1 p. 116-
1 p.
 artikel
71 100P Activities of a surgical quality assurance committee in a multicenter randomized trial Hooper, Frank
 1994
 15 3S1 p. 132-
1 p.
 artikel
72 66P Adherence in the training levels comparison trial Lee, Jeannette
 1994
 15 3S1 p. 114-
1 p.
 artikel
73 21P A generalized SAS-based tables program Hope, Mary Anne
 1994
 15 3S1 p. 89-
1 p.
 artikel
74 41P A mathematical model for the determination of the optimum treatment threshold in the prevention of cardiac lipid risk Cucherat, M.
 1994
 15 3S1 p. 100-101
2 p.
 artikel
75 63P Analysis of study data to monitor quality of blood pressure data collection Similo, Shari L.
 1994
 15 3S1 p. 112-113
2 p.
 artikel
76 24P An object-based approach to data management in clinical trials Urbauer, Diana L.
 1994
 15 3S1 p. 90-91
2 p.
 artikel
77 50P An ophthalmic clinical trial with a group sequential design and multiple comparisons Stricklin, Marcella
 1994
 15 3S1 p. 105-
1 p.
 artikel
78 59P A picture is worth a thousand words Kames, Margaret K.
 1994
 15 3S1 p. 110-
1 p.
 artikel
79 70P Application of relational databases for optimized clinical trials management Azaria, Erez
 1994
 15 3S1 p. 116-117
2 p.
 artikel
80 07P A SAS solution to the randomization test applied to the equality of means of two independent samples Foster, Gary A.
 1994
 15 3S1 p. 81-
1 p.
 artikel
81 32P Assessment of therapeutic achievement in a long-term anticoagulant trial in 1700 post-myocardial infarction patients Azar, Aida J.
 1994
 15 3S1 p. 95-
1 p.
 artikel
82 60P Association between food frequency questionnaire estimates and serum concentrations of β-carotene, retinol, retinyl palmitate, and α-tocopherol among participants in the caret lung cancer chemoprevention trial Goodman, Gary
 1994
 15 3S1 p. 111-
1 p.
 artikel
83 53P A system of remote clinic monitoring for multi-center trials Beck, Roy W.
 1994
 15 3S1 p. 107-
1 p.
 artikel
84 42P A treatment allocation system which preserves randomization schedules and intent-to-treat Forman, Sandra
 1994
 15 3S1 p. 101-
1 p.
 artikel
85 55P Awareness of clinical trials results and influence on prescription behavior: A survey of US physicians Schron, Eleanor
 1994
 15 3S1 p. 108-
1 p.
 artikel
86 104P Case study approach in protocol-specific training Brasler, Mary
 1994
 15 3S1 p. 134-
1 p.
 artikel
87 30P Classification and reduction of queries on multi-centre trials Koski, Beverly
 1994
 15 3S1 p. 94-
1 p.
 artikel
88 79P Comparison of composite endpoints in clinical trials Zhang, Ji
 1994
 15 3S1 p. 121-122
2 p.
 artikel
89 91P Coordinating a multi-center cooperative aggreement of independent clinical trials Hirst, Kathryn
 1994
 15 3S1 p. 127-
1 p.
 artikel
90 36P Critical reading of a meta-analysis of clinical trials Nony, Patrice
 1994
 15 3S1 p. 97-98
2 p.
 artikel
91 06P Data analytic strategy for predicting infrequent but clinically important events in longitudinal data Funderburk, Frank R.
 1994
 15 3S1 p. 80-
1 p.
 artikel
92 22P Data management aspects of a large-scale multicentre clinical trial: The GISSI-3 trial Bonfanti, E.
 1994
 15 3S1 p. 89-90
2 p.
 artikel
93 75P Decreasing mortality rate with later enrollment time in CIBIS Nemoz, Chantel
 1994
 15 3S1 p. 119-120
2 p.
 artikel
94 99P Design issues in wound healing trials Haley, Harold B.
 1994
 15 3S1 p. 131-
1 p.
 artikel
95 17P Design of a comprehensive security system for a clinical research database Wu, D.
 1994
 15 3S1 p. 86-87
2 p.
 artikel
96 43P Developing a protocol and materials for the close-out unmasking process Wasilauskas, Carol H.
 1994
 15 3S1 p. 101-102
2 p.
 artikel
97 48P Development of a drug accountability system for a national institutes of health sponsored trial Maddy, Noel
 1994
 15 3S1 p. 104-
1 p.
 artikel
98 12P Development of a training program for the clinical trials office Trochanowski, Bonnie J.
 1994
 15 3S1 p. 84-
1 p.
 artikel
99 108P Development of a user's manual for a general purpose clinical research database Speakman, J.
 1994
 15 3S1 p. 136-
1 p.
 artikel
100 08P Development of clinical/data management standard operating procedures Eull, Karen
 1994
 15 3S1 p. 81-
1 p.
 artikel
101 93P Differences in patient populations between cardiovascular and noncardiovascular specialties: The dig experience Egan, Debra
 1994
 15 3S1 p. 128-129
2 p.
 artikel
102 03P Dilution of the benefit from primary prevention of coronary heart disease by cholesterol-lowering interventions Cucherat, M.
 1994
 15 3S1 p. 79-
1 p.
 artikel
103 82P Disease severity and compliance Gordon, Mae O.
 1994
 15 3S1 p. 123-
1 p.
 artikel
104 68P Drug loss in the field during multicenter clinical trials Barnhill, Jamie
 1994
 15 3S1 p. 115-
1 p.
 artikel
105 57P Effective recruitment strategies for clinical trials in rare neuromuscular diseases Herr, Barbara
 1994
 15 3S1 p. 109-
1 p.
 artikel
106 78P Efficient treatment of longitudinal data for clinical trial planning: A gee approach Gregori, Dario
 1994
 15 3S1 p. 121-
1 p.
 artikel
107 101P Ejection fraction does not reflect different patterns of left ventricular remodelling in a 3-month post-myocardial infarction trial Zamolla, L.
 1994
 15 3S1 p. 132-133
2 p.
 artikel
108 20P Electronic events coding Cacaceli, Cynthia
 1994
 15 3S1 p. 88-
1 p.
 artikel
109 94P Enhancing recruitment with an ultrasound screening program to detect undiagnosed abdominal aortic aneurysms Johnson, Gary R.
 1994
 15 3S1 p. 129-
1 p.
 artikel
110 86P Equivalence testing: “No difference” is not synonymous with “equivalent” Lion, Laurence
 1994
 15 3S1 p. 125-
1 p.
 artikel
111 67P Errors in documenting drug adminitration in a trial of buprenorphine for opiate dependency Raisch, Dennis W.
 1994
 15 3S1 p. 114-115
2 p.
 artikel
112 09P Establishing a training program for new data managers in clinical research Quinlivan, Susan M.
 1994
 15 3S1 p. 82-
1 p.
 artikel
113 16P Establishing the reference ranges and stability for renal functional parameters Kristoffersen, Doris Tove
 1994
 15 3S1 p. 86-
1 p.
 artikel
114 40P Evaluation of designs for phase I clinical trials Lee, J.Jack
 1994
 15 3S1 p. 100-
1 p.
 artikel
115 96P Factors affecting response to a questionnaire mailout Goldsmith, Laurie J.
 1994
 15 3S1 p. 130-
1 p.
 artikel
116 29P FDA device tracking requirements system development for compliance Overfelt, Jolene
 1994
 15 3S1 p. 93-
1 p.
 artikel
117 18P Fifteen years of the society for clinical trials Marsh, Marta J.
 1994
 15 3S1 p. 87-
1 p.
 artikel
118 26P Form and data classification in a relational database Fain, Katherine T.
 1994
 15 3S1 p. 91-92
2 p.
 artikel
119 54P Gender, race and age distribution in multicenter, randomized clinical trials Manos, Kelly S.
 1994
 15 3S1 p. 107-108
2 p.
 artikel
120 65P Generating customized reports with minimal word processing Schactman, Mark
 1994
 15 3S1 p. 113-114
2 p.
 artikel
121 73P GISSI-3: The centralized quality control project on 14,209 echocardiograms Torta, D.
 1994
 15 3S1 p. 118-
1 p.
 artikel
122 74P Health economic data collection within a management trial Bersinic, Snezana
 1994
 15 3S1 p. 119-
1 p.
 artikel
123 92P Inclusion of patients only with low ejection fraction in heart failure trial biases the population against women and the elderly Garg, Rekha
 1994
 15 3S1 p. 128-
1 p.
 artikel
124 71P Incorporating quality of life surveys into a relational database management system—A general design for handling questionnaire data Marks, Linda D.
 1994
 15 3S1 p. 117-
1 p.
 artikel
125 02P Increased efficiency in applying missing data methodology to carotid atherosclerosis outcome measures Hoen, Helena
 1994
 15 3S1 p. 78-
1 p.
 artikel
126 45P Interventions after acute myocardial infarction in the post timi-save-gusto era: How to design a phase II trial? Ahn, Sylvie
 1994
 15 3S1 p. 103-
1 p.
 artikel
127 28P IONDT tracking system: Where is form 2034 for patient ICMORE and who is responsible? Crawley, Barbara E.
 1994
 15 3S1 p. 93-
1 p.
 artikel
128 76P J-shaped compliance distribution: Revised Dunbar-Jacob, Jacqueline
 1994
 15 3S1 p. 120-
1 p.
 artikel
129 47P Measurement issues in wound healing trials Bell, Margie
 1994
 15 3S1 p. 104-
1 p.
 artikel
130 77P Measurement of health quality of life in the multicenter study of hydroxyurea in sickle cell anemia Barton, F.
 1994
 15 3S1 p. 120-
1 p.
 artikel
131 39P Methods for monitoring clinical trials Case, L.Douglas
 1994
 15 3S1 p. 99-100
2 p.
 artikel
132 19P Monitoring study medications over time in a multicenter clinical trial with three categories of medication Mirenzi, Evelyn D.
 1994
 15 3S1 p. 88-
1 p.
 artikel
133 98P Multiple studies in single site: Logistical and ethical considerations Torner, James C.
 1994
 15 3S1 p. 131-
1 p.
 artikel
134 05P Multivariate adjustments Marsh, Marta J.
 1994
 15 3S1 p. 80-
1 p.
 artikel
135 01P Neural networks in predicting angiographic outcome LaBree, Laurie
 1994
 15 3S1 p. 78-
1 p.
 artikel
136 51P New Guidelines for NHLBI clinical trials Monsees, David
 1994
 15 3S1 p. 106-
1 p.
 artikel
137 95P On the likelihood of finding subgroup differences in clinical trials Holbrook, Janet T.
 1994
 15 3S1 p. 129-130
2 p.
 artikel
138 31P Optimal intensity of long-term oral anticoagulant therapy in 3404 post-myocardial infarction patients Azar, Aida J.
 1994
 15 3S1 p. 94-95
2 p.
 artikel
139 44P Participation in the IONDT: Race, gender, and age Crawley, Barbara E.
 1994
 15 3S1 p. 102-
1 p.
 artikel
140 90P Patient characteristics in phase I and II cancer trials Winget, Marcy
 1994
 15 3S1 p. 127-
1 p.
 artikel
141 15P Patient randomization and medication distribution independent of the pharmaceutical sponsor de Craen, Anton J.M.
 1994
 15 3S1 p. 85-86
2 p.
 artikel
142 46P Patient recruitment in the asymptomatic carotid atherosclerosis study (ACAS) Reed III, James F.
 1994
 15 3S1 p. 103-104
2 p.
 artikel
143 61P Placebo-emergent adverse events differ among indications Wilson, Michael G.
 1994
 15 3S1 p. 111-112
2 p.
 artikel
144 52P Planning the next-step: A screening promotion and nutrition intervention trial in the work site Vernon, Sally W.
 1994
 15 3S1 p. 106-
1 p.
 artikel
145 87P Practical issues in applying the restricted mean life Chappell, Rick
 1994
 15 3S1 p. 125-
1 p.
 artikel
146 89P Prevention of restenosis after coronary angioplasty: PRESANCE, a clinical trial with a factorial design using the change in lumen volume as the main end-point Rosenberg, Yves
 1994
 15 3S1 p. 126-
1 p.
 artikel
147 34P Process of adjudication for fetal/neonatal infection in a multicentre RCT Weston, J.
 1994
 15 3S1 p. 96-97
2 p.
 artikel
148 107P Protecting patient's rights: The DIG study experience Collins, Joseph F.
 1994
 15 3S1 p. 135-
1 p.
 artikel
149 35P Record linkage — An aid to adverse event reporting in clinical trials Macleod, Margaret
 1994
 15 3S1 p. 97-
1 p.
 artikel
150 10P Role of client/server computing in standardization and harmonization of clinical trials data and management Sparkes, Simon
 1994
 15 3S1 p. 82-83
2 p.
 artikel
151 106P Selection of a quality of life instrument for epilepsy clinical trials Cramer, Joyce
 1994
 15 3S1 p. 135-
1 p.
 artikel
152 102P Study design of the pilot phase of the african american study of kidney disease and hypertension (AASK) Kusek, John W.
 1994
 15 3S1 p. 133-
1 p.
 artikel
153 14P Study documentation from trial initiation to posterity: The experience of the NICHD networks Zachary, Julia
 1994
 15 3S1 p. 85-
1 p.
 artikel
154 109P Successful strategies for the recruitment of adolescents to school-based primary care studies Yallop, JJ
 1994
 15 3S1 p. 136-137
2 p.
 artikel
155 83P Summarizing patient diary data from asthma clinical trials Shingo, Sumiko
 1994
 15 3S1 p. 123-
1 p.
 artikel
156 62P Surveying physicians by telephone: Methodological considerations Parker, Albert C.E.
 1994
 15 3S1 p. 112-
1 p.
 artikel
157 49P Survey of refraction and visual acuity protocols in multicenter clinical trials McCaffrey, Lee
 1994
 15 3S1 p. 105-
1 p.
 artikel
158 80P Survival estimates for time-dependent covariates Marks, Gary F.
 1994
 15 3S1 p. 122-
1 p.
 artikel
159 37P The effects of aggregation on medication compliance history in repeated measures anova: A simulation study Rohay, Jeffrey M.
 1994
 15 3S1 p. 98-
1 p.
 artikel
160 84P The graphical representation of the relationship between survival and time-dependent variables: A SAS macro for realization of the Simon & Makuch method Ansari, H.
 1994
 15 3S1 p. 124-
1 p.
 artikel
161 72P The Pennsylvania emergency medical service helicopter registry Wasser, Thomas E.
 1994
 15 3S1 p. 117-118
2 p.
 artikel
162 56P The perceived role of regional nurse coordinators in clinical trials Martin, Sylvia
 1994
 15 3S1 p. 108-109
2 p.
 artikel
163 38P Thrombolysis in acute stroke pooling project (TAS-PP): A prospective pooled individual patient database Cornu, Catherine
 1994
 15 3S1 p. 99-
1 p.
 artikel
164 81P Tightening the clinical trial by randomization Tiwari, Jawahar
 1994
 15 3S1 p. 122-123
2 p.
 artikel
165 103P Tracking and evaluation of adverse events associated with misoprostol in a large multi-center trial with two phases: Treatment of ulceration and prevention of NSAID-induced ulceration Djuric, Peter E.
 1994
 15 3S1 p. 133-
1 p.
 artikel
166 13P Transferring crucial research data from existing systems to an integrated system— The data manager's perspective Marks, Linda D.
 1994
 15 3S1 p. 84-85
2 p.
 artikel
167 11P Transferring crucial research data from existing systems to an integrated system— The design and technique perspective Lin, Kai H.
 1994
 15 3S1 p. 83-
1 p.
 artikel
168 33P Trial to assess coronary atherosclerosis progression/regression by angiotensin converting enzyme inhibition and cholesterol lowering in normochelesterolemic subjects Teo, Koon
 1994
 15 3S1 p. 96-
1 p.
 artikel
169 23P Trial workload measurement tool for study coordinators (SC) Ottaway, Jon
 1994
 15 3S1 p. 90-
1 p.
 artikel
170 97P Unique design features of clinical trials in subarachnoid hemorrhage Torner, James C.
 1994
 15 3S1 p. 130-131
2 p.
 artikel
171 64P Use of journals to track technical issues in multicenter clinical trials: The stop/IT bone journal Fowler, Sarah E.
 1994
 15 3S1 p. 113-
1 p.
 artikel
172 88P Use of trough to peak ratio statistics in the assessment of dosing schedules of antihypertensive agents Makris, Lukas
 1994
 15 3S1 p. 126-
1 p.
 artikel
173 105P Utilities of placebo washout in clinical trials Yoo, Kisook
 1994
 15 3S1 p. 134-
1 p.
 artikel
174 27P Verification and tracking of records in a clinical trial database Orme, Constance
 1994
 15 3S1 p. 92-
1 p.
 artikel
175 25P Visual imaging as an alternative method of data management and analysis in a pilot multicenter controlled trial in ophthalmology Ballantyne, Margaret
 1994
 15 3S1 p. 91-
1 p.
 artikel
176 10S Intention-to treat versus treatment received analyses in randomized clinical trials: A simulation study Saiontz, Cynthia B.
 1994
 15 3S1 p. 38-
1 p.
 artikel
177 11S Optimal stage I screening criteria to minimize clinical trial recruitment costs Allison, David B.
 1994
 15 3S1 p. 39-
1 p.
 artikel
178 12S Sequential monitoring of clinical trials with correlated categorical data Gange, Stephen J.
 1994
 15 3S1 p. 39-40
2 p.
 artikel
                             178 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland